speb/financial-data huggingface dataset:
Financial ratios for CHV.DE — annual report dated 2024-12-31
Total revenue: 193414000000
Gross profit: 56926000000
Operating income: 18917000000
Net income: 17749000000
Capital expenditures: 16448000000
Operating cash flow: 31492000000
Depreciation & amortization: 17711000000
Net tangible assets: 147740000000
Owner earnings: 19012000000
Return on net tangible assets (%): 12.868552863137944
Capex to operating income (%): 86.94824760797167
Buffett classification: The Gruesome
Stock price: 134.05208333333334
P/E ratio: 15.041851661307211
Shares outstanding: 1991597732
Book value: 153157000000
P/B ratio: 1.7431643681747597
Market cap (USD): 266977825136.5417
Debt to equity: 0.1602342694098213
Current ratio: 1.0610249494268376
Quick ratio: 0.8256911665542819
Effective tax rate (%): 35.47226059768778
Interest coverage ratio: 31.846801346801346
COGS to revenue (%): 70.56779757411563
SG&A to revenue (%): 2.4993020153660024
Free cash flow (dilution-adjusted): 15044000000
Buyback yield (%): 5.704219064714968
Retained earnings: 205852000000
Inventory turnover: 15.041657482918227
Receivables turnover: 9.350899245793851
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.66242329883689
FCF margin (%): 7.77813395100665
Revenue growth (%): -1.7769268661794804
Rule of 40 score: 6.001207084827169
Financial ratios for CHV.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 134.05208333333334
Shares outstanding: 1991597732
Market cap (USD): 266977825136.5417
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHV.DE — quarterly report dated 2025-03-31
Total revenue: 46101000000
Gross profit: 13368000000
Operating income: 4297000000
Net income: 3512000000
Capital expenditures: 3927000000
Operating cash flow: 5189000000
Depreciation & amortization: 4235000000
Net tangible assets: 144676000000
Owner earnings: 3820000000
Return on net tangible assets (%): 2.640382648124084
Capex to operating income (%): 91.38934140097743
Buffett classification: The Gruesome
Stock price: 159.05434782608697
P/E ratio: 22.549279498517507
Shares outstanding: 1991597732
Book value: 150080000000
P/B ratio: 2.1106894882407645
Market cap (USD): 316772278395.17395
Debt to equity: 0.19776785714285713
Current ratio: 1.0804436726233824
Quick ratio: 0.8236793456949191
Effective tax rate (%): 37.09475192548809
Interest coverage ratio: 20.2688679245283
COGS to revenue (%): 71.00279820394351
SG&A to revenue (%): 2.6485325697924123
Free cash flow (dilution-adjusted): 1262000000
Buyback yield (%): 1.2365349707506716
Retained earnings: 206359000000
Inventory turnover: 3.5707428820770155
Receivables turnover: 2.3569018404907975
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.947030970343687
FCF margin (%): 2.7374677338886357
Rule of 40 score: 2.7374677338886357
Financial ratios for CHV.DE — quarterly report dated 2025-06-30
Total revenue: 44375000000
Gross profit: 13173000000
Operating income: 4057000000
Net income: 2515000000
Capital expenditures: 3712000000
Operating cash flow: 8576000000
Depreciation & amortization: 4409000000
Net tangible assets: 141849000000
Owner earnings: 3212000000
Return on net tangible assets (%): 2.2643797277386515
Capex to operating income (%): 91.49617944293813
Buffett classification: The Gruesome
Stock price: 136.97647058823532
P/E ratio: 45.26331975458672
Shares outstanding: 1991597732
Book value: 147258000000
P/B ratio: 1.852544704945702
Market cap (USD): 272802028160.89417
Debt to equity: 0.20010457835907047
Current ratio: 0.9960949837769547
Quick ratio: 0.7430441898527005
Effective tax rate (%): 39.35374969857728
Interest coverage ratio: 14.806569343065693
COGS to revenue (%): 70.31436619718309
SG&A to revenue (%): 2.003380281690141
Free cash flow (dilution-adjusted): 4864000000
Buyback yield (%): 0.9523389607894492
Retained earnings: 205905000000
Inventory turnover: 3.540451605582662
Receivables turnover: 2.5123138764649267
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8783016116263027
FCF margin (%): 10.961126760563381
Revenue growth (%): -3.7439534934166288
Rule of 40 score: 7.217173267146753
Financial ratios for CHV.DE — quarterly report dated 2025-09-30
Total revenue: 48169000000
Gross profit: 14990000000
Operating income: 4297000000
Net income: 3613000000
Capital expenditures: 4444000000
Operating cash flow: 9385000000
Depreciation & amortization: 5849000000
Net tangible assets: 185275000000
Owner earnings: 5018000000
Return on net tangible assets (%): 2.7084064228849005
Capex to operating income (%): 103.4209913893414
Buffett classification: The Gruesome
Stock price: 149.6235294117647
P/E ratio: 30.91181346787405
Shares outstanding: 1991597732
Book value: 195600000000
P/B ratio: 1.523465653529171
Market cap (USD): 297989881830.3059
Debt to equity: 0.21239263803680983
Current ratio: 1.152063599458728
Quick ratio: 0.8578597203428056
Effective tax rate (%): 33.26560768378278
Interest coverage ratio: 11.613513513513514
COGS to revenue (%): 68.88040025742697
SG&A to revenue (%): 3.163860574228238
Free cash flow (dilution-adjusted): 4941000000
Buyback yield (%): 0.8611030630433422
Retained earnings: 206006000000
Inventory turnover: 3.1792832502874666
Receivables turnover: 2.692961368591715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.476485161272588
FCF margin (%): 10.257634578255724
Revenue growth (%): 8.549859154929578
Rule of 40 score: 18.807493733185304
Financial ratios for CHV.DE — quarterly report dated 2025-12-31
Total revenue: 45787000000
Gross profit: 14555000000
Operating income: 4023000000
Net income: 2845000000
Capital expenditures: 5264000000
Operating cash flow: 10789000000
Depreciation & amortization: 5964000000
Net tangible assets: 181882000000
Owner earnings: 3545000000
Return on net tangible assets (%): 1.949065877876865
Capex to operating income (%): 130.84762614963955
Buffett classification: The Gruesome
Stock price: 148.49411764705883
P/E ratio: 23.687669036541735
Shares outstanding: 1991597732
Book value: 192176000000
P/B ratio: 1.5389046911228432
Market cap (USD): 295740547921.2235
Debt to equity: 0.2120868370660228
Current ratio: 1.1547009315002845
Quick ratio: 0.8638392188576391
Effective tax rate (%): 38.138725809958686
Interest coverage ratio: 11.14404432132964
COGS to revenue (%): 68.21150108109289
SG&A to revenue (%): 3.2585668421167577
Free cash flow (dilution-adjusted): 5525000000
Buyback yield (%): 1.0137263966923393
Retained earnings: 205365000000
Inventory turnover: 3.216146637833385
Receivables turnover: 2.533167358229599
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.384258064516129
FCF margin (%): 12.06674383558652
Revenue growth (%): -4.94508916523075
Rule of 40 score: 7.1216546703557695
Financial ratios for CHV.DE — annual report dated 2025-12-31
Total revenue: 184432000000
Gross profit: 56086000000
Operating income: 16674000000
Net income: 12485000000
Capital expenditures: 17347000000
Operating cash flow: 33939000000
Depreciation & amortization: 20457000000
Net tangible assets: 181882000000
Owner earnings: 15595000000
Return on net tangible assets (%): 8.574240441604996
Capex to operating income (%): 104.03622406141298
Buffett classification: The Gruesome
Stock price: 148.49411764705883
P/E ratio: 23.687669036541735
Shares outstanding: 1991597732
Book value: 192176000000
P/B ratio: 1.5389046911228432
Market cap (USD): 295740547921.2235
Debt to equity: 0.2120868370660228
Current ratio: 1.1547009315002845
Quick ratio: 0.8638392188576391
Effective tax rate (%): 36.762396798865424
Interest coverage ratio: 13.700903861955629
COGS to revenue (%): 69.58987594343715
SG&A to revenue (%): 2.779344148520864
Free cash flow (dilution-adjusted): 16592000000
Buyback yield (%): 4.084323264058294
Retained earnings: 205365000000
Inventory turnover: 13.216558541859747
Receivables turnover: 10.203706777316736
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.7372903225806455
FCF margin (%): 8.996269627830312
Revenue growth (%): -4.6439244315302926
Rule of 40 score: 4.3523451963000195
Financial ratios for CVR.AX — annual report dated 2022-06-30
Total revenue: 668.2758620689656
Gross profit: 668.2758620689656
Operating income: -202851.03448275864
Net income: -202851.03448275864
Capital expenditures: 150660
Net tangible assets: 3606723.4482758623
Owner earnings: -353511.0344827586
Return on net tangible assets (%): -9.801445537826002
Buffett classification: The Gruesome
Stock price: 0.13793103448275862
Shares outstanding: 85172105
Book value: 3606723.4482758623
P/B ratio: 3.257215786073098
Market cap (USD): 11747876.551724138
Debt to equity: 0.00021033514227929484
Current ratio: 12.182157433454202
Quick ratio: 12.182157433454202
COGS to revenue (%): 0
SG&A to revenue (%): 24349.638802889574
Free cash flow (dilution-adjusted): -238453.10344827586
Buyback yield (%): 0
Retained earnings: -234591.72413793104
Receivables turnover: 0.02270703472840606
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.624246976288919
FCF margin (%): -35681.836945304436
Rule of 40 score: -35681.836945304436
Financial ratios for CVR.AX — annual report dated 2023-06-30
Total revenue: 6583.443708609271
Gross profit: 6583.443708609271
Operating income: -542623.8410596027
Net income: -505765.5629139073
Capital expenditures: 1204751.6556291392
Net tangible assets: 3120697.3509933776
Owner earnings: -1710517.2185430464
Return on net tangible assets (%): -54.81201879440684
Buffett classification: The Gruesome
Stock price: 0.09271523178807947
Shares outstanding: 85172105
Book value: 3120697.350993377
P/B ratio: 2.530444502873679
Market cap (USD): 7896751.456953643
Debt to equity: 0
Current ratio: 7.167790370840511
Quick ratio: 7.167790370840511
COGS to revenue (%): 0
SG&A to revenue (%): 7212.473594205814
Free cash flow (dilution-adjusted): -1627874.834437086
Buyback yield (%): 0
Retained earnings: -731035.761589404
Receivables turnover: 0.7005144105418927
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.387903408412072
FCF margin (%): -24726.79810884217
Revenue growth (%): 885.1386354472077
Rule of 40 score: -23841.65947339496
Financial ratios for CVR.AX — annual report dated 2024-06-30
Total revenue: 2646
Gross profit: 2646
Operating income: -518998
Net income: -490360
Capital expenditures: 685172.6666666666
Net tangible assets: 2763418
Owner earnings: -1175532.6666666665
Return on net tangible assets (%): -42.539082638481275
Buffett classification: The Gruesome
Stock price: 0.10666666666666667
Shares outstanding: 85172105
Book value: 2763418
P/B ratio: 3.2876041674959544
Market cap (USD): 9085024.533333333
Debt to equity: 0
Current ratio: 1.3022158752079345
Quick ratio: 1.3022158752079345
COGS to revenue (%): 0
SG&A to revenue (%): 16216.553287981858
Free cash flow (dilution-adjusted): -1064679.3333333333
Buyback yield (%): 0
Retained earnings: -1226269.3333333333
Receivables turnover: 0.2295148325912219
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.78101684218602
FCF margin (%): -40237.31418493323
Revenue growth (%): -59.80826878583644
Rule of 40 score: -40297.122453719065
Financial ratios for EMR.V — annual report dated 2021-12-31
Operating income: -1844085.0393700788
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.31496062992125984
Shares outstanding: 67835392
Market cap (USD): 21365477.79527559
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -19669.85294117647
Operating income: -1705989.7058823528
Net income: -1155061.0294117646
Capital expenditures: 392822.0588235294
Operating cash flow: -1563092.6470588234
Depreciation & amortization: 19669.85294117647
Net tangible assets: 987911.7647058823
Owner earnings: -1528213.2352941176
Return on net tangible assets (%): -154.69126797463454
Buffett classification: The Gruesome
Stock price: 0.1838235294117647
Shares outstanding: 67835392
Book value: 987911.7647058822
P/B ratio: 12.622322784244844
Market cap (USD): 12469741.176470587
Debt to equity: 0.012535353836077288
Current ratio: 0.47675807129423164
Quick ratio: 0.47675807129423164
Interest coverage ratio: -603.4189856957087
Free cash flow (dilution-adjusted): -1599530.1470588234
Buyback yield (%): 0
Retained earnings: -41453000
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -172.68644496710235
Rule of 40 score: 0
Financial ratios for EMR.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -17923.484848484848
Operating income: -1479811.3636363635
Net income: -625947.7272727273
Capital expenditures: 40131.81818181818
Operating cash flow: -832076.5151515151
Depreciation & amortization: 17923.484848484848
Net tangible assets: 747370.4545454545
Owner earnings: -648156.0606060605
Return on net tangible assets (%): -86.72487073365303
Buffett classification: The Gruesome
Stock price: 0.06818181818181818
Shares outstanding: 67835392
Book value: 747370.4545454544
P/B ratio: 6.188551253941852
Market cap (USD): 4625140.363636363
Debt to equity: 0.02696626252243979
Current ratio: 0.18497831035630657
Quick ratio: 0.18497831035630657
Interest coverage ratio: -1561.431654676259
Free cash flow (dilution-adjusted): -1012319.6969696969
Buyback yield (%): 0
Retained earnings: -43335099.24242424
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -198.00239019836218
Rule of 40 score: 0
Financial ratios for EMR.V — quarterly report dated 2024-09-30
Capital expenditures: 72592.59259259258
Buffett classification: The Gruesome
Stock price: 0.06666666666666667
Shares outstanding: 67835392
Market cap (USD): 4522359.466666667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -1969.93006993007
Operating income: -461367.1328671329
Net income: -203877.62237762238
Capital expenditures: 167832.16783216785
Operating cash flow: -499404.1958041958
Depreciation & amortization: 1969.93006993007
Net tangible assets: 294165.034965035
Owner earnings: -369739.8601398602
Return on net tangible assets (%): -125.69130120573581
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 67835392
Book value: 294165.03496503504
P/B ratio: 9.675657829675552
Market cap (USD): 2846240.223776224
Debt to equity: 0
Current ratio: 0.08433005547444751
Quick ratio: 0.08433005547444751
Free cash flow (dilution-adjusted): -448312.5874125874
Buyback yield (%): 0
Retained earnings: -40383657.34265734
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -156.83955536115016
Rule of 40 score: 0
Financial ratios for EMR.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -5272.027972027972
Operating income: -803988.1118881119
Net income: -382027.27272727276
Capital expenditures: 118117.48251748252
Operating cash flow: -674109.0909090909
Depreciation & amortization: 5272.027972027972
Net tangible assets: 294165.034965035
Owner earnings: -494872.72727272735
Return on net tangible assets (%): -168.22962230421058
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 67835392
Book value: 294165.03496503504
P/B ratio: 9.675657829675552
Market cap (USD): 2846240.223776224
Debt to equity: 0
Current ratio: 0.08433005547444751
Quick ratio: 0.08433005547444751
Interest coverage ratio: -1190.1687370600414
Free cash flow (dilution-adjusted): -811564.3356643356
Buyback yield (%): 0
Retained earnings: -40383657.34265734
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -273.31192233083556
Rule of 40 score: 0
Financial ratios for EMR.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -1048.951048951049
Operating income: -90458.04195804195
Net income: -90475.52447552448
Capital expenditures: 0
Operating cash flow: -773.4265734265734
Depreciation & amortization: 1048.951048951049
Net tangible assets: 542885.3146853147
Owner earnings: -89426.57342657344
Return on net tangible assets (%): -16.472461311356316
Buffett classification: The Gruesome
Stock price: 0.027972027972027975
Shares outstanding: 67835392
Book value: 542885.3146853147
P/B ratio: 3.4952013458263678
Market cap (USD): 1897493.4825174827
Debt to equity: 0
Current ratio: 0.10036248892365353
Quick ratio: 0.10036248892365353
Free cash flow (dilution-adjusted): -773.4265734265734
Buyback yield (%): 0
Retained earnings: -40474132.86713287
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.66245881240613
Rule of 40 score: 0
Financial ratios for EMR.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -1094.890510948905
Operating income: -110059.85401459853
Net income: -110378.10218978101
Capital expenditures: 0
Operating cash flow: -50164.96350364963
Depreciation & amortization: 1094.890510948905
Net tangible assets: 435472.2627737226
Owner earnings: -109283.21167883211
Return on net tangible assets (%): -25.09533236003534
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 67835392
Book value: 435472.26277372264
P/B ratio: 4.548155086264262
Market cap (USD): 1980595.3868613138
Debt to equity: 0
Current ratio: 0.07732344721247499
Quick ratio: 0.07732344721247499
Free cash flow (dilution-adjusted): -50164.96350364963
Buyback yield (%): 0
Retained earnings: -42357100.729927
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.273677205886045
Rule of 40 score: 0
Financial ratios for EMR.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -2151.079136690648
Operating income: -146023.0215827338
Net income: 285845.3237410072
Capital expenditures: 212230.21582733814
Operating cash flow: -36401.438848920865
Depreciation & amortization: 2151.079136690648
Net tangible assets: 731861.1510791368
Owner earnings: 75766.1870503597
Return on net tangible assets (%): 10.352535715093182
Buffett classification: The Gruesome
Stock price: 0.03597122302158274
P/E ratio: 2.134127980872082
Shares outstanding: 67835392
Book value: 731861.1510791369
P/B ratio: 3.3341324522971387
Market cap (USD): 2440122.0143884895
Debt to equity: 0.021607471637797394
Current ratio: 0.2216747754043519
Quick ratio: 0.2216747754043519
Free cash flow (dilution-adjusted): -36401.438848920865
Buyback yield (%): 0
Retained earnings: -41461800.719424464
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.95228485176749
Rule of 40 score: 0
Financial ratios for EMR.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -10.21897810218978
Operating income: -114504.37956204379
Net income: 115916.05839416057
Capital expenditures: 343065.6934306569
Operating cash flow: -274645.98540145985
Depreciation & amortization: 10.21897810218978
Net tangible assets: 1012384.6715328466
Owner earnings: -227139.41605839416
Return on net tangible assets (%): -22.436078147497383
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
P/E ratio: 12.322790764281986
Shares outstanding: 67835392
Book value: 1012384.6715328465
P/B ratio: 2.445458039016069
Market cap (USD): 2475744.2335766423
Debt to equity: 0.5215776583004499
Current ratio: 0.43250669902587663
Quick ratio: 0.43250669902587663
Interest coverage ratio: -2.1595082734506206
Free cash flow (dilution-adjusted): -402383.2116788321
Buyback yield (%): 0
Retained earnings: -41951166.42335766
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.310362827666413
Rule of 40 score: 0
Financial ratios for EMR.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -4382.481751824817
Operating income: -467138.68613138684
Net income: 201118.24817518247
Capital expenditures: 127737.22627737225
Operating cash flow: -362551.0948905109
Depreciation & amortization: 4382.481751824817
Net tangible assets: 1012384.6715328466
Owner earnings: 77763.50364963504
Return on net tangible assets (%): 7.681220966324362
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
P/E ratio: 12.309893587677657
Shares outstanding: 67835392
Book value: 1012384.6715328465
P/B ratio: 2.445458039016069
Market cap (USD): 2475744.2335766423
Debt to equity: 0.5215776583004499
Current ratio: 0.43250669902587663
Quick ratio: 0.43250669902587663
Interest coverage ratio: -8.810054789240384
Free cash flow (dilution-adjusted): -490288.3211678832
Buyback yield (%): 0
Retained earnings: -41951166.42335766
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -46.14241002129107
Rule of 40 score: 0
Financial ratios for EPN.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.05072463768115943
Shares outstanding: 389104011
Market cap (USD): 19737159.978260875
Buyback yield (%): 0
Capitalized R&D asset: 123983.33333333334
Rule of 40 score: 0
Financial ratios for EPN.AX — annual report dated 2022-12-31
Total revenue: 4805536.486486486
Gross profit: 490437.83783783787
Operating income: -5663566.891891892
Net income: -8565857.432432432
Capital expenditures: 357703.3783783784
Depreciation & amortization: 1253723.6486486488
Net tangible assets: 14768822.972972972
Owner earnings: -7669837.162162161
Return on net tangible assets (%): -51.93262304110494
Buffett classification: The Gruesome
Stock price: 0.02027027027027027
Shares outstanding: 389104011
Book value: 6354268.91891892
P/B ratio: 1.241251128470985
Market cap (USD): 7887243.466216217
Debt to equity: 0.3402053184505245
Current ratio: 0.744080056313561
Quick ratio: 0.6699273959382837
Interest coverage ratio: -14.51319108854833
COGS to revenue (%): 89.79431663422005
R&D to revenue (%): 5.280466196507014
SG&A to revenue (%): 59.832802648521685
Free cash flow (dilution-adjusted): -2094631.0810810812
Buyback yield (%): 24.749475018904395
Retained earnings: -33088896.621621624
Inventory turnover: 10.450711185877084
Receivables turnover: 2.2614159918957535
Capitalized R&D asset: 336823.5630630631
ROCI (R&D-adjusted, %): -62.01293380171745
FCF margin (%): -43.58787175940365
Rule of 40 score: -43.58787175940365
Financial ratios for EPN.AX — annual report dated 2023-12-31
Total revenue: 4555835.616438356
Gross profit: 3413682.8767123288
Operating income: -1654716.4383561644
Net income: -747253.4246575342
Capital expenditures: 67889.72602739726
Depreciation & amortization: 1012890.4109589042
Net tangible assets: 5163851.369863014
Owner earnings: 197747.2602739727
Buffett classification: The Gruesome
Stock price: 0.013698630136986302
Shares outstanding: 389104011
Book value: 5163851.369863014
P/B ratio: 1.0322124998822824
Market cap (USD): 5330191.93150685
Debt to equity: 0.45811882736457066
Current ratio: 0.328915063705989
Quick ratio: 0.328915063705989
Interest coverage ratio: -5.06496289152585
COGS to revenue (%): 25.070104276917153
R&D to revenue (%): 0.8080559030116427
SG&A to revenue (%): 46.348533868950256
Free cash flow (dilution-adjusted): -550318.493150685
Buyback yield (%): 0
Retained earnings: -32943260.95890411
Receivables turnover: 5.253836596418256
Capitalized R&D asset: 247743.86754905593
ROCI (R&D-adjusted, %): -30.50444267144557
Rosenberg metric: 11.519962768725511
FCF margin (%): -12.079419440969886
Revenue growth (%): -5.196108088041922
Rule of 40 score: -17.275527529011807
Financial ratios for EPN.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -1290195.6521739129
Buffett classification: The Gruesome
Stock price: 0.012422360248447204
Shares outstanding: 389104011
Book value: -1290195.652173913
Market cap (USD): 4833590.198757764
Debt to equity: -3.7957630770045463
Current ratio: 0.3207479930781889
Quick ratio: 0.2747575418668024
Buyback yield (%): 0
Retained earnings: -33286271.428571425
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPN.AX — annual report dated 2024-12-31
Total revenue: 3478373.2919254657
Gross profit: 2656359.6273291926
Operating income: -3066336.0248447205
Net income: -3412258.3850931674
Capital expenditures: 60703.10559006211
Depreciation & amortization: 874303.7267080744
Net tangible assets: -1290195.6521739129
Owner earnings: -2598657.763975155
Buffett classification: The Gruesome
Stock price: 0.012422360248447204
Shares outstanding: 389104011
Book value: -1290195.652173913
Market cap (USD): 4833590.198757764
Debt to equity: -3.7957630770045463
Current ratio: 0.3207479930781889
Quick ratio: 0.2747575418668024
Interest coverage ratio: -4.365968130773844
COGS to revenue (%): 23.632129032972326
SG&A to revenue (%): 91.93070723964101
Free cash flow (dilution-adjusted): -2175981.9875776395
Buyback yield (%): 0
Retained earnings: -33286271.428571425
Inventory turnover: 2.5018232824376976
Receivables turnover: 5.1286949450102615
Capitalized R&D asset: 108404.23889300259
Rosenberg metric: -20.57177837499774
FCF margin (%): -62.55746019637579
Revenue growth (%): -23.65015806595816
Rule of 40 score: -86.20761826233395
Financial ratios for FCN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 153.42
Shares outstanding: 30144043
Market cap (USD): 4624699077.059999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FCN — annual report dated 2022-12-31
Total revenue: 3028908000
Gross profit: 962931000
Operating income: 312218000
Net income: 235514000
Capital expenditures: 53319000
Operating cash flow: 188794000
Depreciation & amortization: 45541000
Net tangible assets: 428614000
Owner earnings: 227736000
Return on net tangible assets (%): 53.13312210987042
Capex to operating income (%): 17.077490727632615
Buffett classification: The Great
Stock price: 158.8
P/E ratio: 20.325220701954027
Shares outstanding: 30144043
Book value: 1681721000
P/B ratio: 2.8464138988571825
Market cap (USD): 4786874028.400001
Debt to equity: 0.3381642971693878
Current ratio: 1.9631184770192245
Quick ratio: 1.9631184770192245
Effective tax rate (%): 20.901833423453983
Interest coverage ratio: 31.07574400318503
COGS to revenue (%): 68.20864153021485
SG&A to revenue (%): 21.165053544049538
Free cash flow (dilution-adjusted): 110061000
Buyback yield (%): 1.784546647628259
Retained earnings: 1858103000
Receivables turnover: 3.2415192474395607
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.630607188917423
FCF margin (%): 3.633685803596544
Rule of 40 score: 3.633685803596544
Financial ratios for FCN — annual report dated 2023-12-31
Total revenue: 3489242000
Gross profit: 1135026000
Operating income: 377561000
Net income: 274892000
Capital expenditures: 49479000
Operating cash flow: 224461000
Depreciation & amortization: 47238000
Net tangible assets: 728566000
Owner earnings: 272651000
Return on net tangible assets (%): 37.42296511228907
Capex to operating income (%): 13.10490225420528
Buffett classification: The Great
Stock price: 199.15
P/E ratio: 21.83834438052035
Shares outstanding: 30144043
Book value: 1981420000
P/B ratio: 3.0297393603829574
Market cap (USD): 6003186163.45
Debt to equity: 0.13002695036892734
Current ratio: 1.7422793578182039
Quick ratio: 1.7422793578182039
Effective tax rate (%): 23.292304172026686
Interest coverage ratio: 26.34575395994697
COGS to revenue (%): 67.47069993998697
SG&A to revenue (%): 21.53206914281096
Free cash flow (dilution-adjusted): 145448000
Buyback yield (%): 0.3495143983331304
Retained earnings: 2114765000
Receivables turnover: 3.038877339420537
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.51763607795623
FCF margin (%): 4.168469828117397
Revenue growth (%): 15.1980185598242
Rule of 40 score: 19.366488387941597
Financial ratios for FCN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 191.13
Shares outstanding: 30144043
Market cap (USD): 5761430938.59
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FCN — annual report dated 2024-12-31
Total revenue: 3698652000
Gross profit: 1181926000
Operating income: 355592000
Net income: 280088000
Capital expenditures: 35408000
Operating cash flow: 395097000
Depreciation & amortization: 48093000
Net tangible assets: 1014964000
Owner earnings: 292773000
Return on net tangible assets (%): 28.8456536389468
Capex to operating income (%): 9.957479358365767
Buffett classification: The Great
Stock price: 191.13
P/E ratio: 20.57007418593442
Shares outstanding: 30144043
Book value: 2258290000
P/B ratio: 2.5512360850865035
Market cap (USD): 5761430938.59
Debt to equity: 0.10722537849434749
Current ratio: 1.952773195643938
Quick ratio: 1.952773195643938
Effective tax rate (%): 20.150753625584784
Interest coverage ratio: 51.156955833693
COGS to revenue (%): 68.04441185599511
SG&A to revenue (%): 22.228395642520574
Free cash flow (dilution-adjusted): 321253000
Buyback yield (%): 0.17733441759349483
Retained earnings: 2394853000
Receivables turnover: 3.451316830648412
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.342683928495713
FCF margin (%): 8.685677917252015
Revenue growth (%): 6.001590030155547
Rule of 40 score: 14.687267947407562
Financial ratios for FCN — quarterly report dated 2025-03-31
Total revenue: 898282000
Gross profit: 289354000
Operating income: 104002000
Net income: 61824000
Capital expenditures: 17803000
Operating cash flow: -465210000
Depreciation & amortization: 11162000
Net tangible assets: 902149000
Owner earnings: 55183000
Return on net tangible assets (%): 6.116838792704975
Capex to operating income (%): 17.117940039614624
Buffett classification: The Great
Stock price: 164.08
P/E ratio: 20.0004633129529
Shares outstanding: 30144043
Book value: 2149638000
P/B ratio: 2.3008685999410132
Market cap (USD): 4946034575.440001
Debt to equity: 0.1680250349128551
Current ratio: 2.2421578211523463
Quick ratio: 2.2421578211523463
Effective tax rate (%): 23.27719933979474
Interest coverage ratio: 107.4400826446281
COGS to revenue (%): 67.78806655371031
SG&A to revenue (%): 20.52083866758991
Free cash flow (dilution-adjusted): -492766000
Buyback yield (%): 3.6926753586988865
Retained earnings: 2311287000
Receivables turnover: 0.7662116332073206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.837130235967903
FCF margin (%): -54.8564927272282
Rule of 40 score: -54.8564927272282
Financial ratios for FCN — quarterly report dated 2025-06-30
Total revenue: 943662000
Gross profit: 302521000
Operating income: 99264000
Net income: 71698000
Capital expenditures: 17425000
Operating cash flow: 55693000
Depreciation & amortization: 12376000
Net tangible assets: 642043000
Owner earnings: 66649000
Return on net tangible assets (%): 10.380768889311152
Capex to operating income (%): 17.554198903932946
Buffett classification: The Great
Stock price: 161.5
P/E ratio: 16.9748910168345
Shares outstanding: 30144043
Book value: 1899881000
P/B ratio: 2.562404142417341
Market cap (USD): 4868262944.5
Debt to equity: 0.3614679024633648
Current ratio: 2.1065514032314128
Quick ratio: 2.1065514032314128
Effective tax rate (%): 22.01568431242454
Interest coverage ratio: 13.551399317406144
COGS to revenue (%): 67.94180543457298
SG&A to revenue (%): 21.427587420072015
Free cash flow (dilution-adjusted): 28350000
Buyback yield (%): 7.272347530035926
Retained earnings: 2027779000
Receivables turnover: 0.7776212089748534
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.569794840369063
FCF margin (%): 3.00425364166407
Revenue growth (%): 5.051865672472564
Rule of 40 score: 8.056119314136634
Financial ratios for FCN — quarterly report dated 2025-09-30
Total revenue: 956167000
Gross profit: 317934000
Operating income: 117670000
Net income: 82818000
Capital expenditures: 14914000
Operating cash flow: 201893000
Depreciation & amortization: 12903000
Net tangible assets: 494075000
Owner earnings: 80807000
Return on net tangible assets (%): 16.35520922936801
Capex to operating income (%): 12.674428486445144
Buffett classification: The Great
Stock price: 161.65
P/E ratio: 22.523733710594435
Shares outstanding: 30144043
Book value: 1749655000
P/B ratio: 2.7849973571646984
Market cap (USD): 4872784550.95
Debt to equity: 0.4206474990783897
Current ratio: 1.8523005803209998
Quick ratio: 1.8523005803209998
Effective tax rate (%): 25.875340111699842
Interest coverage ratio: 15.413937647367042
COGS to revenue (%): 66.74911391001781
SG&A to revenue (%): 20.862882739103107
Free cash flow (dilution-adjusted): 177956000
Buyback yield (%): 4.806512529972993
Retained earnings: 1882483000
Receivables turnover: 0.77780154882374
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.389443252821039
FCF margin (%): 18.61139319805013
Revenue growth (%): 1.3251566768609948
Rule of 40 score: 19.936549874911126
Financial ratios for FCN — quarterly report dated 2025-12-31
Total revenue: 990746000
Gross profit: 307666000
Operating income: 93436000
Net income: 54531000
Capital expenditures: 8389000
Operating cash flow: 359756000
Depreciation & amortization: 12802000
Net tangible assets: 477407000
Owner earnings: 58944000
Return on net tangible assets (%): 12.346697890898122
Capex to operating income (%): 8.978338113789118
Buffett classification: The Great
Stock price: 170.83
P/E ratio: 19.01091983154343
Shares outstanding: 30144043
Book value: 1733731000
P/B ratio: 2.9701879159396705
Market cap (USD): 5149506865.690001
Debt to equity: 0.36148687426134735
Current ratio: 1.5562388419065432
Quick ratio: 1.5562388419065432
Effective tax rate (%): 37.14947615919228
Interest coverage ratio: 12.3969749237097
COGS to revenue (%): 68.94602652950404
SG&A to revenue (%): 21.559612655514126
Free cash flow (dilution-adjusted): 340737000
Buyback yield (%): 1.7048622769092365
Retained earnings: 1862672000
Receivables turnover: 0.8692744566957874
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7146484032569766
FCF margin (%): 34.39196322770922
Revenue growth (%): 3.616418470831978
Rule of 40 score: 38.0083816985412
Financial ratios for FCN — annual report dated 2025-12-31
Total revenue: 3788857000
Gross profit: 1217475000
Operating income: 414372000
Net income: 270871000
Capital expenditures: 58531000
Operating cash flow: 152132000
Depreciation & amortization: 49243000
Net tangible assets: 477407000
Owner earnings: 261583000
Return on net tangible assets (%): 54.79245172358177
Capex to operating income (%): 14.125230469240199
Buffett classification: The Great
Stock price: 170.83
P/E ratio: 19.01091983154343
Shares outstanding: 30144043
Book value: 1733731000
P/B ratio: 2.9701879159396705
Market cap (USD): 5149506865.690001
Debt to equity: 0.36148687426134735
Current ratio: 1.5562388419065432
Quick ratio: 1.5562388419065432
Effective tax rate (%): 26.99111347102916
Interest coverage ratio: 19.36679753224902
COGS to revenue (%): 67.86695829375455
SG&A to revenue (%): 21.10462337322311
Free cash flow (dilution-adjusted): 54277000
Buyback yield (%): 16.675014178953663
Retained earnings: 1862672000
Receivables turnover: 3.324319866214984
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.473803332274496
FCF margin (%): 1.4325428486744154
Revenue growth (%): 2.4388615095445583
Rule of 40 score: 3.8714043582189737
Financial ratios for FLX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.31
Shares outstanding: 57937317
Market cap (USD): 481459104.27000004
Buyback yield (%): 0
Retained earnings: -351478356.1643836
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FLX — annual report dated 2024-12-31
Total revenue: 612076849.3150685
Gross profit: 67200410.95890412
Operating income: -3531095.890410959
Net income: -20065753.424657535
Capital expenditures: 147397.2602739726
Operating cash flow: 299863.01369863015
Depreciation & amortization: 406986.30136986304
Net tangible assets: 102337534.24657534
Owner earnings: -19806164.383561645
Return on net tangible assets (%): -19.353763532977094
Buffett classification: The Gruesome
Stock price: 8.31
Shares outstanding: 57937317
Book value: 102337534.24657536
P/B ratio: 4.704618963262853
Market cap (USD): 481459104.27000004
Debt to equity: 0.056870629557842424
Current ratio: 1.8704059577657508
Quick ratio: 1.8704059577657508
COGS to revenue (%): 89.02091934467
R&D to revenue (%): 3.2195795988550997
SG&A to revenue (%): 8.33640506687203
Free cash flow (dilution-adjusted): -21777945.205479454
Buyback yield (%): 0
Retained earnings: -351478356.1643836
Receivables turnover: 101.15827484718133
Capitalized R&D asset: 33891306.50469012
ROCI (R&D-adjusted, %): -0.23789920529328573
Rosenberg metric: 0.9162649500567801
FCF margin (%): -3.55804099270371
Revenue growth (%): -3.907405613946363
Rule of 40 score: -7.465446606650072
Financial ratios for FLX — quarterly report dated 2025-03-31
Total revenue: 132336363.63636364
Gross profit: 17448209.366391186
Operating income: 1372038.567493113
Net income: -1414462.8099173554
Capital expenditures: 0
Net tangible assets: 103625068.87052342
Owner earnings: -1414462.8099173554
Return on net tangible assets (%): -1.364981297802259
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.7
Shares outstanding: 57937317
Book value: 103625068.87052342
P/B ratio: 3.7460049786313765
Market cap (USD): 388180023.90000004
Debt to equity: 0.05265459553008169
Current ratio: 2.152814084029643
Quick ratio: 2.152814084029643
COGS to revenue (%): 86.81525705637817
R&D to revenue (%): 3.0686059606853724
SG&A to revenue (%): 9.079355761364416
Buyback yield (%): 0
Receivables turnover: 45.082914926563745
Capitalized R&D asset: 4060881.5426997244
ROCI (R&D-adjusted, %): 3.6641307633650437
Rule of 40 score: 0
Financial ratios for FLX — quarterly report dated 2025-06-30
Total revenue: 142895118.54951185
Gross profit: 17111854.951185495
Operating income: 2693444.909344491
Net income: 7460948.39609484
Capital expenditures: 0
Net tangible assets: 112740306.83403069
Owner earnings: 7460948.39609484
Return on net tangible assets (%): 6.617818068455665
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.15
P/E ratio: 30.183243794909284
Shares outstanding: 57937317
Book value: 112740306.83403069
P/B ratio: 1.6187870485279854
Market cap (USD): 182502548.54999998
Debt to equity: 0.046734822131062365
Current ratio: 2.212779841883398
Quick ratio: 2.212779841883398
Effective tax rate (%): 0
COGS to revenue (%): 88.02488487718605
R&D to revenue (%): 1.8772973321178499
SG&A to revenue (%): 8.212907419589717
Buyback yield (%): 0
Receivables turnover: 49.866543366105326
Capitalized R&D asset: 5403356.88186544
ROCI (R&D-adjusted, %): 2.574173290655716
Rosenberg metric: -0.08282793075074
Revenue growth (%): 7.9787252898695
Rule of 40 score: 7.9787252898695
Financial ratios for FLX — quarterly report dated 2025-09-30
Total revenue: 141213764.0449438
Gross profit: 15703089.887640448
Operating income: 1983988.7640449437
Net income: 6143820.224719101
Capital expenditures: 0
Net tangible assets: 117877247.19101124
Owner earnings: 6143820.224719101
Return on net tangible assets (%): 5.212049289515135
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.21
P/E ratio: 15.256285646563398
Shares outstanding: 57937317
Book value: 117877247.19101124
P/B ratio: 1.5777327007699402
Market cap (USD): 185978787.57
Debt to equity: 0.029719309031724584
Current ratio: 2.278022275513944
Quick ratio: 2.278022275513944
Effective tax rate (%): 0.0913575735428467
COGS to revenue (%): 88.87991549984982
R&D to revenue (%): 1.7617127591646262
SG&A to revenue (%): 7.953417501954366
Buyback yield (%): 0
Receivables turnover: 38.26465215405693
Capitalized R&D asset: 5625191.194299252
ROCI (R&D-adjusted, %): 1.1101027501515133
Rosenberg metric: -0.5251557401277936
Revenue growth (%): -1.1766353683981627
Rule of 40 score: -1.1766353683981627
Financial ratios for FLX — annual report dated 2025-12-31
Total revenue: 570295285.7142857
Gross profit: 67014142.85714286
Operating income: 6614428.571428572
Net income: 15632714.285714285
Capital expenditures: 6142.857142857143
Operating cash flow: 14146714.285714285
Depreciation & amortization: 254142.85714285713
Net tangible assets: 119346714.28571428
Owner earnings: 15880714.285714285
Return on net tangible assets (%): 13.30636907832761
Capex to operating income (%): 0.09287056435066196
Buffett classification: The Great
Stock price: 3.18
P/E ratio: 11.78558404463168
Shares outstanding: 57937317
Book value: 119346714.2857143
P/B ratio: 1.5437431115106406
Market cap (USD): 184240668.06
Debt to equity: 0.027060413417330297
Current ratio: 2.349112802453709
Quick ratio: 2.349112802453709
Effective tax rate (%): 0.25249302681712943
COGS to revenue (%): 88.24922026609273
R&D to revenue (%): 2.1160215998378784
SG&A to revenue (%): 8.474932910695136
Free cash flow (dilution-adjusted): 7495142.857142857
Buyback yield (%): 4.248325269095237
Retained earnings: -350909000
Receivables turnover: 68.09263649854162
Capitalized R&D asset: 29487320.77253999
ROCI (R&D-adjusted, %): 2.5429690565045937
Rosenberg metric: -0.00945221014665493
FCF margin (%): 1.3142564992020425
Revenue growth (%): -6.826195705251313
Rule of 40 score: -5.51193920604927
Financial ratios for FLX — quarterly report dated 2025-12-31
Total revenue: 143043571.42857143
Gross profit: 15418142.857142856
Operating income: 414571.4285714286
Net income: 3208428.5714285714
Capital expenditures: 0
Net tangible assets: 119346714.28571428
Owner earnings: 3208428.5714285714
Return on net tangible assets (%): 2.688325850134123
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.18
P/E ratio: 11.964663035650096
Shares outstanding: 57937317
Book value: 119346714.2857143
P/B ratio: 1.5437431115106406
Market cap (USD): 184240668.06
Debt to equity: 0.027060413417330297
Current ratio: 2.349112802453709
Quick ratio: 2.349112802453709
Effective tax rate (%): 0.8913993204183399
COGS to revenue (%): 89.22136611721703
R&D to revenue (%): 1.802048326933352
SG&A to revenue (%): 8.686763773275876
Buyback yield (%): 0
Retained earnings: -350909000
Receivables turnover: 17.079246763436643
Capitalized R&D asset: 5129774.349886163
ROCI (R&D-adjusted, %): 0.32426410650103726
Rosenberg metric: -0.11453863586873227
Revenue growth (%): 1.2957712698921149
Rule of 40 score: 1.2957712698921149
Financial ratios for GPRK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.45
Shares outstanding: 64895753
Market cap (USD): 613264865.8499999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GPRK — annual report dated 2022-12-31
Total revenue: 216491.51322262397
Gross profit: 122337.47857421315
Operating income: 108307.12047737994
Net income: 46293.10682675588
Capital expenditures: 34819.19833007778
Operating cash flow: 96422.9507047047
Depreciation & amortization: 19944.18466501517
Net tangible assets: 23841.151124247906
Owner earnings: 31418.09316169328
Return on net tangible assets (%): 131.78094043344728
Capex to operating income (%): 32.14857728338351
Buffett classification: The Good
Stock price: 13.13
P/E ratio: 18406.22276830047
Shares outstanding: 64895753
Book value: 23841.151124247903
P/B ratio: 35739.93690360788
Market cap (USD): 852081236.8900001
Debt to equity: 4.582714019985293
Current ratio: 1.0392267242695994
Quick ratio: 0.9762387903384173
Effective tax rate (%): 43.16791969795573
Interest coverage ratio: 12.388217807766717
COGS to revenue (%): 43.49086633783641
SG&A to revenue (%): 5.270208340677548
Free cash flow (dilution-adjusted): 59326.99824468403
Buyback yield (%): 0.0008778744776390959
Retained earnings: -16737.79374727988
Inventory turnover: 31.624705556325345
Receivables turnover: 11.17762513312034
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 70.49850970704331
FCF margin (%): 27.403844779668802
Rule of 40 score: 27.403844779668802
Financial ratios for GPRK — annual report dated 2023-12-31
Total revenue: 195227.7852954443
Gross profit: 103967.00818351698
Operating income: 80882.01559378827
Net income: 28627.617758876215
Capital expenditures: 51302.27463109737
Operating cash flow: 77566.33803724467
Depreciation & amortization: 31170.565113731554
Net tangible assets: 45368.90263547909
Owner earnings: 8495.908241510399
Return on net tangible assets (%): 18.726281104419932
Capex to operating income (%): 63.428531366912885
Buffett classification: The Good
Stock price: 7.69
P/E ratio: 17432.408968617943
Shares outstanding: 64895753
Book value: 45368.902635479084
P/B ratio: 10999.788656552993
Market cap (USD): 499048340.57000005
Debt to equity: 3.0296500397682085
Current ratio: 1.1699639546635554
Quick ratio: 1.1111809944348776
Effective tax rate (%): 48.22221911434952
Interest coverage ratio: 8.414050140769541
COGS to revenue (%): 46.63885349898011
SG&A to revenue (%): 7.059879725653026
Free cash flow (dilution-adjusted): 24375.28191249436
Buyback yield (%): 0.0016134323686207287
Retained earnings: 7611.315162059411
Inventory turnover: 26.06692739079103
Receivables turnover: 8.328495244378471
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.92361381465281
FCF margin (%): 12.485559817014
Revenue growth (%): -9.821968358322481
Rule of 40 score: 2.663591458691519
Financial ratios for GPRK — quarterly report dated 2024-09-30
Capital expenditures: 10989.852391902012
Operating cash flow: 30244.2269178405
Depreciation & amortization: 7908.7217746470105
Buffett classification: The Gruesome
Stock price: 7.38
Shares outstanding: 64895753
Market cap (USD): 478930657.14
Free cash flow (dilution-adjusted): 29856.84239742924
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GPRK — quarterly report dated 2024-12-31
Total revenue: 32638.75798572392
Gross profit: 14725.07307235469
Operating income: 10118.619085795006
Net income: 3484.7621145674593
Capital expenditures: 10759.975199685681
Operating cash flow: 45764.75584635614
Depreciation & amortization: 7861.154577270467
Owner earnings: 585.9414921522457
Capex to operating income (%): 106.33837590339814
Buffett classification: The Gruesome
Stock price: 8.85
P/E ratio: 41202.77045950434
Shares outstanding: 64895753
Market cap (USD): 574327414.05
Effective tax rate (%): 53.433886680222145
Interest coverage ratio: 4.96866287498606
COGS to revenue (%): 54.884701560042856
Free cash flow (dilution-adjusted): 34665.025424864354
Buyback yield (%): 0
Retained earnings: 28621.87923700425
Inventory turnover: 19.437407589945785
Capitalized R&D asset: 0
FCF margin (%): 106.20816343571258
Rule of 40 score: 106.20816343571258
Financial ratios for GPRK — annual report dated 2024-12-31
Total revenue: 150101.6313247047
Gross profit: 83154.86342793942
Operating income: 65481.232839068216
Net income: 21888.54847757411
Capital expenditures: 43448.24297040541
Operating cash flow: 106975.42906587754
Depreciation & amortization: 29673.848613612467
Net tangible assets: 46169.23716322558
Owner earnings: 8114.154120781168
Return on net tangible assets (%): 17.574806558086692
Capex to operating income (%): 66.35220671117662
Buffett classification: The Good
Stock price: 8.85
P/E ratio: 26238.71631499122
Shares outstanding: 64895753
Book value: 46169.237163225596
P/B ratio: 12439.612376949975
Market cap (USD): 574327414.05
Debt to equity: 2.657550014511217
Current ratio: 1.1666463234356732
Quick ratio: 1.137984067181486
Effective tax rate (%): 60.20208860681089
Interest coverage ratio: 7.955768328688502
COGS to revenue (%): 44.58809876490907
SG&A to revenue (%): 9.14357648319093
Free cash flow (dilution-adjusted): 62102.30356765694
Buyback yield (%): 0.0017276946363729189
Retained earnings: 28621.87923700425
Inventory turnover: 27.888047695656287
Receivables turnover: 5.510355004919044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.680207173116564
FCF margin (%): 41.37350341870384
Revenue growth (%): -23.11461655032801
Rule of 40 score: 18.258886868375832
Financial ratios for GPRK — quarterly report dated 2025-03-31
Operating income: 13645.496784889343
Capital expenditures: 0
Net tangible assets: 51066.33089584399
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.86
Shares outstanding: 64895753
Book value: 51066.330895844
P/B ratio: 9988.589538973762
Market cap (USD): 510080618.58000004
Debt to equity: 3.2444954934002865
Current ratio: 1.958989490006892
Quick ratio: 1.9247200206753965
Buyback yield (%): 0
Retained earnings: 32079.12104958275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.829284859328471
Rule of 40 score: 0